Pfizer Entered into a Clinical Trial Collaboration with NiKang to Evaluate Combination Therapies for the Treatment of Advanced Clear Cell Renal Cell Carcinoma
Shots: The companies collaborated to evaluate NKT2152 (HIF2α inhibitor) + pa...
Taiho Exercised its Option to License Arcus’s Domvanalimab and AB308 for NSCLC in Japan and Other Countries
Shots: Arcus will receive an option exercise fees along with an additional milesto...
AstraZeneca Signs an Agreement with Genetron Health to Develop and Commercialize NGS-based MRD Assay for Solid Tumors in China
Shots: Under the agreement, the companies will jointly invest the funds & will...
